MKI67 and neoplasm: An immunohistochemical analysis also confirmed that in the disease control group, there were highly degenerated cells and a proliferative marker, Ki-67, in the tumor cells, and it was also shown that the KD group had a lower tumor burden and Ki-67 index than the other treatment groups.